For example, after the initial 2.5 mg dose, the next steps often involve increasing the dose incrementally, with 5 mg or higher doses based on how the patient responds
This lack of correlation raises questions about the reliability of BMI as a surrogate for muscle mass
As redundant as the phrase might sound, its all about moderation and balance
Uricosuric agents, exemplified by benzbromarone, enhance urinary urate excretion via regulation of renal transporters (e.g., OAT1), although hepatotoxicity limits chronic use (Sun et al., 2025)
Though launched five years after Semaglutide (in 2022), it achieved $3.84 billion in Q1 sales